Company News
10X Genomics Stock Up 3.8% on Cleveland Clinic Partnership
10X Genomics shares rose about 3.8% after announcing a multi‑year bladder‑cancer biomarker collaboration with Cleveland Clinic.
The partnership will use 10X’s Flex Apex, Xenium and new Atera platforms
